{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:00:54Z","timestamp":1791460854174,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.phrs.2018.02.033","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T14:09:20Z","timestamp":1520604560000},"page":"17-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Disruption of TFG\u03b2-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-9528","authenticated-orcid":false,"given":"Adriana","family":"Carino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6583-3693","authenticated-orcid":false,"given":"Paolo","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-4222","authenticated-orcid":false,"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.02.033_bib0005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2018.02.033_bib0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"5418","key":"10.1016\/j.phrs.2018.02.033_bib0015","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.02.033_bib0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156802612799436641","article-title":"General molecular biology and architecture of nuclear receptors","volume":"12","author":"Pawlak","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2018.02.033_bib0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.02.033_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1507\/endocrj.K07E-103","article-title":"Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner","volume":"55","author":"Chanda","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.phrs.2018.02.033_bib0040","doi-asserted-by":"crossref","first-page":"39169","DOI":"10.1074\/jbc.M605947200","article-title":"Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation","volume":"281","author":"Suh","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","article-title":"Histological severity and clinical outcomes of nonalcoholic fatty liver disease in non-obese patients","volume":"65","author":"Leung","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12072-015-9613-5","article-title":"New cellular and molecular targets for the treatment of portal hypertension","volume":"9","author":"Gracia-Sancho","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phrs.2018.02.033_bib0055","article-title":"A randomized placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","author":"Friedman","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0065","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis in dependent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2018.02.033_bib0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-\u03b2 signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2018.02.033_bib0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.105.084905","article-title":"A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis","volume":"314","author":"Fiorucci","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2018.02.033_bib0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.105.085597","article-title":"Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis","volume":"315","author":"Fiorucci","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2018.02.033_bib0090","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00011-010-0306-1","article-title":"SHP-dependent and \u2212independent induction of peroxisome proliferator-activated receptor-\u03b3 by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts","volume":"60","author":"Renga","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.phrs.2018.02.033_bib0100","doi-asserted-by":"crossref","first-page":"41055","DOI":"10.1038\/srep41055","article-title":"Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis","volume":"7","author":"Cipriani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.02.033_bib0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"NASH Clinical Research Network. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2018.02.033_bib0110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0115","first-page":"19008","article-title":"Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists","volume":"6","author":"Sepe","year":"2016","journal-title":"Sci. Reports"},{"key":"10.1016\/j.phrs.2018.02.033_bib0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/jm401873d","article-title":"Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors","volume":"57","author":"D'Amore","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2018.02.033_bib0130","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3748\/wjg.15.2097","article-title":"Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation","volume":"15","author":"Renga","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-022X(02)00010-6","article-title":"Enzymatic assay of gamma-cystathionase activity using pyruvate oxidase-peroxidase sequential reaction","volume":"51","author":"Ogasawara","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.phrs.2018.02.033_bib0140","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0145","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(03)00112-6","article-title":"Structural basis for bile acid binding and activation of the nuclear receptor FXR","volume":"11","author":"Mi","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2018.02.033_bib0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semi empirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2017.00162","article-title":"Targeting bile acid receptors: discovery of a potent and selective farnesoid x receptor agonist as a new lead in the pharmacological approach to liver diseases","volume":"8","author":"Festa","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0160","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4155\/fmc.15.54","article-title":"Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application","volume":"7","author":"Sepe","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.phrs.2018.02.033_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2018.02.033_bib0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.phrs.2016.07.040","article-title":"Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension","volume":"111","author":"Fiorucci","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2018.02.033_bib0175","doi-asserted-by":"crossref","first-page":"H21","DOI":"10.1152\/ajpheart.00577.2016","article-title":"Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators","volume":"312","author":"Fiorucci","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0180","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","article-title":"Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental liver cirrhosis","volume":"117","author":"Shah","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0185","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0190","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1681\/ASN.2008121232","article-title":"The orphan nuclear receptor SHP attenuates renal fibrosis","volume":"20","author":"Jung","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0195","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1111\/liv.12871","article-title":"Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells","volume":"35","author":"Jung","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2018.02.033_bib0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"POISE study group. a placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.phrs.2018.02.033_bib0205","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/toxsci\/kfu228","article-title":"Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients","volume":"143","author":"Bathena","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2018.02.033_bib0215","doi-asserted-by":"crossref","first-page":"e86553","DOI":"10.1371\/journal.pone.0086553","article-title":"Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner","volume":"9","author":"Bae","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.02.033_bib0220","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.23049","article-title":"Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner","volume":"50","author":"Chanda","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0225","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.22196","article-title":"Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis","volume":"47","author":"Park","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0230","doi-asserted-by":"crossref","first-page":"34630","DOI":"10.1038\/srep34630","article-title":"Orphan nuclear receptor SHP regulates iron metabolism through inhibition of BMP6-mediated hepcidin expression","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.02.033_bib0235","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3748\/wjg.15.2097","article-title":"Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation","volume":"15","author":"Renga","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2018.02.033_bib0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.20817","article-title":"The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis","volume":"42","author":"Fiorucci","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2018.02.033_bib0245","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.22037","article-title":"The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats","volume":"47","author":"Distrutti","year":"2008","journal-title":"Hepatology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817315128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817315128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:53:37Z","timestamp":1760910817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817315128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"alternative-id":["S1043661817315128"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.033","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of TFG\u03b2-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}